EDMONTON, AB, Aug. 13, 2025 /CNW/ - AutoCanada Inc. ("AutoCanada" or the "Company") (TSX: ACQ), a multi-location North American automobile dealership group, is pleased...
PITTSBURGH, Aug. 13, 2025 /PRNewswire/ -- MSA Safety Incorporated (NYSE: MSA), a global leader in the development of advanced safety products and solutions that...
On 13 August 2025, the Management Board of AB “Ignitis grupė” (hereinafter – the Group or AB “Ignitis grupė”), legal entity code: 301844044, registered office address: Laisvės Ave. 10, Vilnius, decided to convene the General Meeting of Shareholders (hereinafter – GM) of the Group.
On 13 August 2025, the Management Board of AB “Ignitis grupė” (hereinafter – the Group or AB “Ignitis grupė”), legal entity code: 301844044, registered office address: Laisvės Ave. 10, Vilnius, decided to convene the General Meeting of Shareholders (hereinafter – GM) of the Group.
SINGAPORE, Aug. 13, 2025 /PRNewswire/ -- KBP Biosciences Pte. Ltd. (the "Company") today issued a statement addressing a further decision by the Singapore International...
SEOUL, South Korea, Aug. 12, 2025 /PRNewswire/ -- Within the framework of the Vietnam–Korea Economic Forum 2025, and in the presence of Prime Minister of...
VICTORIA, British Columbia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, today announced its financial results for the second quarter of 2025 and provided a business update. All dollar values are in U.S. dollars unless stated otherwise.
YUPELRI® (revefenacin) net sales of $66.3 million, recognized by Viatris, increased 22% year-over-year1Pivotal Phase 3 CYPRESS study enrollment on track to complete by late...
PHILADELPHIA, Aug. 12, 2025 /PRNewswire/ -- The Pew Charitable Trusts and the Alexander and Margaret Stewart Trust announced today the 2025 class of the...